Press release – For immediate release – 5:45 pm CEST
H2 2025 Financial Communication Calendar
Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, “Median” or the “Company”), manufacturer of eyonis®, a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for early cancer diagnosis, and a globally leading provider of AI-based image analyses and central imaging services for oncology drug developers, announces today its H2 2025 financial communication calendar.
Publication | Date |
H1 2025 results | October 23, 2025, release after market close |
The Company will participate in upcoming investor events:
European MidCap Event 2025 – September 30 – October 1st, 2025 – Paris, France
Portzamparc Biotech and Healthcare Sector Investor Seminar – October 1-2, 2025 (digital)
Investor Access Conference 2025 – October 7-8, 2025 – Paris, France
Please get in touch through the respective event booking systems, if you would like to request a meeting with Median management at these events. Events are for institutional investors only.